Jonas from Switzerland

Registered at the short selling broker Capital, 2 minutes ago.

» Try Capital you too
67.7% of retail investor accounts lose money when trading CFDs with Capital.
Don't show again

Sanofi (SNY) shares information

Sanofi – ADR


24h Change

-0.02 %

SNY

Live rate: Market closed

Stock data per Monday 2 Aug, 2021

SNY
NASDAQ/NGS (GLOBAL SELECT MARKET)
51.56
51.55
-0.01 (-0.02%)
US Market is closed

Live Stock price in graph for Sanofi – ADR (SNY)

  • Latest Volume

    2,094,054 (17.56 %)

  • Volume prev. day

    1,781,247

  • Avg. daily volume

    1,408,375

  • Market cap

    129,799,986,188

  • P/E ratio

    8.59

  • Today high

    n/a

  • Today low

    n/a

  • 52 week high

    54.26 USD

  • 52 week low

    43.13 USD

  • YTD Change

    + 10.10 %

Quick links

 

Latest news about Sanofi – ADR

Below you can find the most recent news posts about Sanofi – ADR, primarily from US and UK based news sources.

Sanofi offers to buy U.S. biotech, mRNA partner Translate Bio -sources

Tuesday, 3 August 2021, 00:27:08
PARIS Sanofi has offered to buy U.S. biotech company Translate Bio, two sources familiar with the situation said on Monday, as the French drugmaker bets on next-generation mRNA technology after setbacks in the COVID-19 vaccine race. Shares in the New York-listed biotech company soared more than 70% to above $50 in extended trading, building []
— Financial Post


Sanofi preps a multibillion-dollar buyout of an mRNA pioneer after falling behind in the race for a Covid-19 jab report

Tuesday, 3 August 2021, 00:08:25
It looks like Sanofi CEO Paul Hudson is dead serious about his intention to vault directly into contention for the future of mRNA vaccines. A year after paying Translate Bio a whopping $425 million in an upfront and equity payment to help guide the pharma giant to the promised land
— Endpoints News


Translate Bio surges in after hours on report of Sanofi bid

Monday, 2 August 2021, 23:49:41
No summary available.
— Seeking Alpha


Global Hydroxychloroquine Market Is Growing Rapidly as Sanofi and Teva Pharmaceutical announces to donate millions of doses of Hydroxychloroquine for the treatment of COVID-19

Monday, 2 August 2021, 15:30:31
Hydroxychloroquine (Plaquenil and Hydrochloroquin) are commonly used in the treatment of osteoarthritis. Hydroxychloroquine and Hydroxyquinone (Dilantin) are considered “anti-inflammatory” medicines. They inhibit the action of prostaglandins and leukotrienes on the skin, joints, and tendons. It can reduce swelling and pain
— OpenPR


Hydroxychloroquine Market 2021-2027 | To Reach USD 2,339.1 Million by 2027, Exhibit a CAGR of 5.5%

Monday, 2 August 2021, 14:20:00
Key Prominent Players Covered in the Hydroxychloroquine Market Research Report Are Sanofi , Zydus Cadia , Ipca Laboratories Ltd , Sandoz International GmbH (part of Novartis AG) , Mylan N.V. , Teva Pharmaceutical Industries Ltd , Bayer AG Key Prominent Players Covered in the Hydroxychloroquine Market Research Report Are Sanofi , Zydus Cadia , Ipca Laboratories Ltd , Sandoz International GmbH (part of Novartis AG) , Mylan N.V. , Teva Pharmaceutical Industries Ltd , Bayer AG
— Intrado Digital Media


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have SNY available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.